Human-induced pluripotent stem cells (iPSCs) represent a promising cell source for the construction of organotypic culture models for chemical toxicity screening and characterization.
Materials and Methods:
To characterize the effects of chemical exposure on the human neurovasculature, we constructed neurovascular unit (NVU) models consisting of endothelial cells (ECs) and astrocytes (ACs) derived from human-iPSCs, as well as human brain-derived pericytes (PCs). The cells were cocultured on synthetic poly(ethylene glycol) (PEG) hydrogels that guided the self-assembly of capillary-like vascular networks. High-content epifluorescence microscopy evaluated dose-dependent changes to multiple aspects of NVU morphology.
Results:
Cultured vascular networks underwent quantifiable morphological changes when incubated with vascular disrupting chemicals. The activity of predicted vascular disrupting chemicals from a panel of 38 compounds (U.S. Environmental Protection Agency) was ranked based on morphological features detected in the NVU model. In addition, unique morphological neurovascular disruption signatures were detected per chemical. A comparison of PEG-based NVU and Matrigel™-based NVU models found greater sensitivity and consistency in chemical detection by the PEG-based NVU models.
Discussion:
We suspect that specific morphological changes may be used for discerning adverse outcome pathways initiated by chemical exposure and rapid mechanistic characterization of chemical exposure to neurovascular function.
Conclusion:
The use of human stem cell-derived vascular tissue and PEG hydrogels in the construction of NVU models leads to rapid detection of adverse chemical effects on neurovascular stability. The use of multiple cell types in coculture elucidates potential mechanisms of action by chemicals applied to the model.
Get full access to this article
View all access options for this article.
References
1.
HartungT, RovidaC. Chemical regulators have overreached. Nature, 2009:460; 1080–1081.
2.
MuellerD, KrämerL, HoffmannE, et al.3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. Toxicol In Vitro, 2014:28; 104–112.
3.
LeCluyseEL, WitekRP, AndersenME, et al.Organotypic liver culture models: Meeting current challenges in toxicity testing. Crit Rev Toxicol, 2012:42; 501–548.
4.
SailiKS, ZurlindenTJ, SchwabAJ, et al.Blood-brain barrier development: Systems modeling and predictive toxicology. Birth Defects Res, 2017:109; 1680–1710.
5.
SweeneyMD, KislerK, MontagneA, et al.The role of brain vasculature in neurodegenerative disorders. Nat Neurosci, 2018:21; 1318–1331.
6.
ZlokovicBV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci, 2011:12; 723–738.
7.
RoherAE, DebbinsJP, Malek-AhmadiM, et al.Cerebral blood flow in Alzheimer's disease. Vasc Health Risk Manag, 2012:8; 599–611.
8.
NelsonAR, SweeneyMD, SagareAP, et al.Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. Biochim Biophys Acta, 2016:1862; 887–900.
9.
DerejkoM, SławekJ, WieczorekD, et al.Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment. Nucl Med Commun, 2006:27; 945–951.
10.
FirbankMJ, CollobySJ, BurnDJ, et al.Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage, 2003:20; 1309–1319.
11.
IchimTE, SolanoF, GlennE, et al.Stem cell therapy for autism. J Transl Med, 2007:5; 30.
12.
BjørklundG, KernJK, UrbinaMA, et al.Cerebral hypoperfusion in autism spectrum disorder. Acta Neurobiol Exp (Wars), 2018:78; 21–29.
13.
RyanCM. Diabetes and brain damage: More (or less) than meets the eye?. Diabetologia, 2006:49; 2229–2233.
14.
MossHE. Retinal vascular changes are a marker for cerebral vascular diseases. Curr Neurol Neurosci Rep, 2015:15; 40.
15.
NielsenRB, EgefjordL, AngleysH, et al.Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease. Alzheimers Dement, 2017:13; 1143–1153.
16.
Di MarcoLY, VenneriA, FarkasE, et al.Vascular dysfunction in the pathogenesis of Alzheimer's disease—A review of endothelium-mediated mechanisms and ensuing vicious circles. Neurobiol Dis, 2015:82; 593–606.
17.
BonkowskiD, KatyshevV, BalabanovRD, et al.The CNS microvascular pericyte: Pericyte-astrocyte crosstalk in the regulation of tissue survival. Fluids Barriers CNS, 2011:8; 8.
18.
Al AhmadA, TaboadaCB, GassmannM, et al.Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult. J Cereb Blood Flow Metab, 2011:31; 693–705.
19.
McCarthyRC, KosmanDJ. Mechanisms and regulation of iron trafficking across the capillary endothelial cells of the blood-brain barrier. Front Mol Neurosci, 2015:8; 31.
20.
AbbottNJ, RönnbäckL, HanssonE. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci, 2006:7; 41–53.
21.
RibattiD. Judah Folkman, a pioneer in the study of angiogenesis. Angiogenesis, 2008:11; 3–10.
22.
HughesC, PostovitL, LajoieG. Matrigel: A complex protein mixture required for optimal growth of cell culture. Proteomics, 2010:10; 1886–1890.
23.
SmithmyerME, SawickiLA, KloxinAM. Hydrogel scaffolds as in vitro models to study fibroblast activation in wound healing and disease. Biomater Sci, 2014:2; 634–650.
NguyenEH, ZanotelliMR, SchwartzMP, et al.Differential effects of cell adhesion, modulus and VEGFR-2 inhibition on capillary network formation in synthetic hydrogel arrays. Biomaterials, 2014:35; 2149–2161.
31.
ZanotelliMR, ArdalaniH, ZhangJ, et al.Stable engineered vascular networks from human induced pluripotent stem cell-derived endothelial cells cultured in synthetic hydrogels. Acta Biomater, 2016:35; 32–41.
32.
BelairDG, SchwartzMP, KnudsenT, et al.Human iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arrays. Acta Biomater, 2016:39; 12–24.
33.
NguyenE, DalyW, LeNN, et al.Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansion. Nat Biomed Eng, 2017:2017; 0096.
34.
SchwartzMP, HouZ, PropsonNE, et al.Human pluripotent stem cell-derived neural constructs for predicting neural toxicity. Proc Natl Acad Sci U S A, 2015:112; 12516–12521.
35.
BarryC, SchmitzMT, PropsonNE, et al.Uniform neural tissue models produced on synthetic hydrogels using standard culture techniques. Exp Biol Med (Maywood), 2017:242; 1679–1689.
NolanDJ, GinsbergM, IsraelyE, et al.Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev Cell, 2013:26; 204–219.
38.
LippmannES, Al-AhmadA, AzarinSM, et al.A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci Rep, 2014:4; 4160.
39.
LippmannES, AzarinSM, KayJE, et al.Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat Biotechnol, 2012:30; 783–791.
40.
KattME, XuZS, GerechtS, et al.Human brain microvascular endothelial cells derived from the BC1 iPS cell line exhibit a blood-brain barrier phenotype. PLoS One, 2016:11; e0152105.
41.
MinamiH, TashiroK, OkadaA, et al.Generation of brain microvascular endothelial-like cells from human induced pluripotent stem cells by co-culture with C6 glioma cells. PLoS One, 2015:10; e0128890.
42.
YuanF, FangKH, CaoSY, et al.Efficient generation of region-specific forebrain neurons from human pluripotent stem cells under highly defined condition. Sci Rep, 2015:5; 18550.
43.
ShaltoukiA, PengJ, LiuQ, et al.Efficient generation of astrocytes from human pluripotent stem cells in defined conditions. Stem Cells, 2013:31; 941–952.
44.
ChandrasekaranA, AvciHX, LeistM, et al.Astrocyte differentiation of human pluripotent stem cells: New tools for neurological disorder research. Front Cell Neurosci, 2016:10; 215.
45.
XuJ, GongT, HengBC, et al.A systematic review: Differentiation of stem cells into functional pericytes. FASEB J, 2017:31; 1775–1786.
46.
IwataY, KlarenWD, LebakkenCS, et al.High-content assay multiplexing for vascular toxicity screening in induced pluripotent stem cell-derived endothelial cells and human umbilical vein endothelial cells. Assay Drug Dev Technol, 2017:15; 267–279.
47.
KnudsenTB, KleinstreuerNC. Disruption of embryonic vascular development in predictive toxicology. Birth Defects Res C Embryo Today, 2011:93; 312–323.
48.
KleinstreuerNC, JudsonRS, ReifDM, et al.Environmental impact on vascular development predicted by high-throughput screening. Environ Health Perspect, 2011:119; 1596–1603.
49.
El-MasriH, KleinstreuerN, HinesRN, et al.Integration of life-stage physiologically based pharmacokinetic models with adverse outcome pathways and environmental exposure models to screen for environmental hazards. Toxicol Sci, 2016:152; 230–243.
50.
USEPA. ToxCast & Tox21 Summary Files from ToxCast Dashboard.
51.
FrancoM, RoswallP, CortezE, et al.Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood, 2011:118; 2906–2917.
52.
ChouCH, SindenJD, CouraudPO, et al.In vitro modeling of the neurovascular environment by coculturing adult human brain endothelial cells with human neural stem cells. PLoS One, 2014:9; e106346.
53.
MorettiR, PansiotJ, BettatiD, et al.Blood-brain barrier dysfunction in disorders of the developing brain. Front Neurosci, 2015:9; 40.
54.
SaundersNR, LiddelowSA, DziegielewskaKM. Barrier mechanisms in the developing brain. Front Pharmacol, 2012:3; 46.
55.
NikolakopoulouAM, ZhaoZ, MontagneA, et al.Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling. PLoS One, 2017:12; e0176225.
56.
WilhelmI, Nyúl-Tóth Á, SuciuM, et al.Heterogeneity of the blood-brain barrier. Tissue Barriers, 2016:4; e1143544.
57.
VillaseñorR, KuenneckeB, OzmenL, et al.Region-specific permeability of the blood-brain barrier upon pericyte loss. J Cereb Blood Flow Metab, 2017:37; 3683–3694.
58.
YoonH, WaltersG, PaulsenAR, et al.Astrocyte heterogeneity across the brain and spinal cord occurs developmentally, in adulthood and in response to demyelination. PLoS One, 2017:12; e0180697.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
